EFFECT OF DIHYDROXYANTHRAQUINONE (NSC 279836) AND THORACIC IRRADIATION ON LONG-TERM SURVIVAL OF RATSKIMLER BF; HENDERSON SD; MANSFIELD CM et al.1982; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2656-2659; BIBL. 18 REF.Article

THE ELECTROCHEMICAL REDUCTION OF 1,4-BIS-(2-((2-HYDROXYETHYL)-AMINO) ETHYLAMINO)-ANTHRACENEDIONE AND DAUNOMYCIN: BIOCHEMICAL SIGNIFICANCE IN SUPEROXIDE FORMATION = LA REDUCTION ELECTROCHIMIQUE DE LA 1,4-BIS-(2-((2-HYDROXYETHYL)-AMINO) ETHYLAMINO)-ANTHRACENEDIONE ET DE LA DAUNOMYCINE: IMPORTANCE BIOCHIMIQUE DANS LA FORMATION DE SUPEROXYDESINHA BK; MOTTEN AG; HANCK KW et al.1983; CHEMICO-BIOLOGICAL INTERACTIONS; ISSN 0009-2797; NLD; DA. 1983; VOL. 43; NO 3; PP. 371-377; BIBL. 22 REF.; GRAPHArticle

CLINICAL KINETICS OF 1,4-DIHYDROXY-5,8-BIS((2-(HYDROXYETHYLAMINO)ETHYL)AMINO)-9,10-ANTHRACE NEDIONESAVARAJ N; LU K; VALDIVIESO M et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 3; PP. 312-316; BIBL. 10 REF.Article

IMPROVED HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY OF THE NEW ANTINEOPLASTIC AGENTS BISANTRENE AND MITOXANTRONEYEI MEI PENG; ORMBERG D; ALBERTS DS et al.1982; JOURNAL OF CHROMATOGRAPHY; ISSN 0021-9673; NLD; DA. 1982-12; VOL. 233; PP. 235-247; BIBL. 15 REF.Article

EFFECT OF 1,4-DIHYDROXY-5,8-BIS (2-(2-HYDROXYETHYLAMINO) ETHYL AMINO)-9,10-ANTHRACENEDIONE (DIHYDROXYANTHRAQUINONE) ON THE REPLICATION OF SIMIAN VIRUS 40 CHROMOSOMESU RT.1981; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1981; VOL. 103; NO 1; PP. 249-255; BIBL. 21 REF.Article

Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cellsWICHERT, Anke; STEGE, Alexandra; MIDORIKAWA, Yutaka et al.Oncogene (Basingstoke). 2004, Vol 23, Num 4, pp 945-955, issn 0950-9232, 11 p.Article

NEW ANTICANCER DRUGSKUHN JG; MYERS JW; CALLAHAN SK et al.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 118-139; BIBL. 100 REF.Article

ACTIVITY OF MITOXANTRONE IN A HUMAN TUMOR CLONING SYSTEMVON HOFF DD; COLTMAN CA JR; FORSETH B et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 5; PP. 1853-1855; BIBL. 15 REF.Article

Mechanism of action of mitoxantroneFOX, Edward J.Neurology. 2004, Vol 63, Num 12, pp S15-S18, issn 0028-3878, SUP6Conference Paper

Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteomeSYMES, Juliane; EVANGELOU, Andreas; IGNATCHENKO, Alex et al.Proteomics. Clinical applications (Print). 2009, Vol 3, Num 3, pp 347-358, issn 1862-8346, 12 p.Article

Mitoxantrone and cytotoxic drugs' mechanisms of actionVOLLMER, Timothy; STEWART, Thomas; BAXTER, Nancy et al.Neurology. 2010, Vol 74, Num 1, issn 0028-3878, S41-S46, SUP1Conference Paper

PHASE I TRIAL OF MITOXANTRONE BY 24-HOUR CONTINUOUS INFUSION = ESSAI PHASE I DE MITOXANTRONE EN PERFUSION CONTINUE DE 24 HEURESANDERSON KC; GARNICK MB; MESHAD MW et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 435-438; ABS. ENG; BIBL. 4 REF.; GRAPHArticle

PHASE II TRIAL OF MITOXANTRONE IN ADVANCED COLORECTAL CANCERBONNEM EM; MITCHELL EP; WOOLLEY PV et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 11; PP. 1995-1996; BIBL. 6 REF.Article

POTENTIAL CARDIOTOXICITY WITH MITOXANTRONE (W.)SCHELL FC; YAP HY; BLUMENSCHEIN G et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 8; PP. 1641-1643; BIBL. 9 REF.Article

Novobiocin sensitizes BCRP/MXR/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantroneYANG, Chih-Hsin; CHEN, Yao-Chang; KUO, Min-Liang et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2519-2523, issn 0250-7005, 5 p.Article

INHIBITION OF ADRIAMYCIN-STIMULATED MICROSOMAL LIPID PEROXIDATION BY MITOXANTRONE AND AMETANTRONE, TWO NEW ANTHRACENEDIONE ANTINEOPLASTIC AGENTSKHARASCH ED; NOVAK RF.1982; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; ISSN 0006-291X; USA; DA. 1982; VOL. 108; NO 3; PP. 1346-1352; BIBL. 20 REF.Article

PHASE II TRIAL OF MITOXANTRONE IN PREVIOUSLY UNTREATED PATIENTS WITH COLORECTAL ADENOCARCINOMA: A SOUTHWEST ONCOLOGY GROUP STUDYCOWAN JD; VON HOFF DD; MCDONALD B et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 9; PP. 1779-1780; BIBL. 4 REF.Article

THE EFFECT OF PREOPERATIVE ADRIAMYCIN AND DIHYDROXYANTHRACENEDIONE ON WOUND HEALINGMULLEN BM; MATTOX DE; VON HOFF DD et al.1981; LARYNGOSCOPE; ISSN 0023-852X; USA; DA. 1981; VOL. 91; NO 9; PART. 1; PP. 1436-1443; BIBL. 14 REF.Article

ANTHRACENEDIONE ACTIVATION BY NADPH-CYTOCHROME P-450 REDUCTASE; COMPARISON WITH ANTHRACYCLINESKHARASCH ED; NOVAK RF.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 20; PP. 2881-2884; BIBL. 20 REF.Article

Bilan de la mitoxantrone en 1989 = Current results of mitoxantrone therapyCOIFFIER, B.Transactions of the Zoological Society of London. 1989, Vol 37, Num 9, pp 1007-1008, issn 0084-5620, 2 p.Conference Paper

Therapeutic Concentrations of Mitoxantrone Elicit Energetic Imbalance in H9c2 Cells as an Earlier EventROSSATO, Luciana Grazziotin; COSTA, Vera Marisa; VILAS-BOAS, Vânia et al.Cardiovascular toxicology. 2013, Vol 13, Num 4, pp 413-425, issn 1530-7905, 13 p.Article

Enhanced expression of membrane transporter and drug resistance in keloid fibroblastsNAN SONG; XIAOLI WU; ZHEN GAO et al.Human pathology. 2012, Vol 43, Num 11, pp 2024-2032, issn 0046-8177, 9 p.Article

Current therapeutic recommendations in multiple sclerosisBERGER, Thomas.Journal of the neurological sciences. 2009, Vol 287, issn 0022-510X, S37-S45, SUP1Conference Paper

Intralesional mitoxantrone biopolymer-mediated chemotherapy prolongs survival in rats with experimental brain tumorsSAINI, Marco; ROSER, Florian; HUSSEIN, Samii et al.Journal of neuro-oncology. 2004, Vol 68, Num 3, pp 225-232, issn 0167-594X, 8 p.Article

Thermodynamical study of interaction of histone H1 chromosomal protein and mitoxantrone anticancer drugJAFARGHOLIZADEH, Naser; JALAL ZARGAR, Seyed; SAFARIAN, Shahrokh et al.Thermochimica acta. 2012, Vol 537, pp 20-24, issn 0040-6031, 5 p.Article